JP2022536679A - ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原 - Google Patents

ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原 Download PDF

Info

Publication number
JP2022536679A
JP2022536679A JP2021573378A JP2021573378A JP2022536679A JP 2022536679 A JP2022536679 A JP 2022536679A JP 2021573378 A JP2021573378 A JP 2021573378A JP 2021573378 A JP2021573378 A JP 2021573378A JP 2022536679 A JP2022536679 A JP 2022536679A
Authority
JP
Japan
Prior art keywords
infection
babesia
subject
sample
microti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536679A5 (https=
Inventor
マアムーン チョウクリ ベン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of JP2022536679A publication Critical patent/JP2022536679A/ja
Publication of JP2022536679A5 publication Critical patent/JP2022536679A5/ja
Priority to JP2025145131A priority Critical patent/JP2025186283A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021573378A 2019-06-12 2020-06-12 ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原 Pending JP2022536679A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025145131A JP2025186283A (ja) 2019-06-12 2025-09-02 ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962860662P 2019-06-12 2019-06-12
US62/860,662 2019-06-12
US201962937645P 2019-11-19 2019-11-19
US62/937,645 2019-11-19
PCT/US2020/037500 WO2020252313A1 (en) 2019-06-12 2020-06-12 Novel secreted antigens for diagnosis of active babesia microti and babesia duncani infection in humans and animals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025145131A Division JP2025186283A (ja) 2019-06-12 2025-09-02 ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原

Publications (2)

Publication Number Publication Date
JP2022536679A true JP2022536679A (ja) 2022-08-18
JP2022536679A5 JP2022536679A5 (https=) 2023-06-15

Family

ID=73781883

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021573378A Pending JP2022536679A (ja) 2019-06-12 2020-06-12 ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原
JP2025145131A Pending JP2025186283A (ja) 2019-06-12 2025-09-02 ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025145131A Pending JP2025186283A (ja) 2019-06-12 2025-09-02 ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原

Country Status (8)

Country Link
US (1) US20220236268A1 (https=)
EP (1) EP3983430A4 (https=)
JP (2) JP2022536679A (https=)
CN (1) CN114072419A (https=)
AU (1) AU2020292378A1 (https=)
BR (1) BR112021025089A2 (https=)
CA (1) CA3143027A1 (https=)
WO (1) WO2020252313A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024517646A (ja) * 2021-04-23 2024-04-23 アイデイー－フイツシユ・テクノロジー・インコーポレーテツド Ｂａｂｅｓｉａ組換えタンパク質を使用するＢａｂｅｓｉａの診断

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119462946B (zh) * 2024-10-21 2025-10-03 华中农业大学 抗邓肯巴贝斯虫ald蛋白的单克隆抗体及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091598A1 (en) * 2001-01-05 2003-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of Babesia infection
US20090074783A1 (en) * 2007-09-14 2009-03-19 New York Blood Center Babesia subtilisin
CN104845981A (zh) * 2015-05-25 2015-08-19 中国疾病预防控制中心寄生虫病预防控制所 田鼠巴贝虫Bm1524抗原及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180372742A1 (en) * 2015-12-10 2018-12-27 Immport Therapeutics, Inc. Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test
CN108893476B (zh) * 2018-06-28 2022-07-05 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 田鼠巴贝虫2d97抗原蛋白及其应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091598A1 (en) * 2001-01-05 2003-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of Babesia infection
US20090074783A1 (en) * 2007-09-14 2009-03-19 New York Blood Center Babesia subtilisin
CN104845981A (zh) * 2015-05-25 2015-08-19 中国疾病预防控制中心寄生虫病预防控制所 田鼠巴贝虫Bm1524抗原及其应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024517646A (ja) * 2021-04-23 2024-04-23 アイデイー－フイツシユ・テクノロジー・インコーポレーテツド Ｂａｂｅｓｉａ組換えタンパク質を使用するＢａｂｅｓｉａの診断

Also Published As

Publication number Publication date
AU2020292378A1 (en) 2022-01-06
JP2025186283A (ja) 2025-12-23
CA3143027A1 (en) 2020-12-17
EP3983430A4 (en) 2023-10-11
EP3983430A1 (en) 2022-04-20
WO2020252313A1 (en) 2020-12-17
US20220236268A1 (en) 2022-07-28
BR112021025089A2 (pt) 2022-02-15
CN114072419A (zh) 2022-02-18

Similar Documents

Publication Publication Date Title
JP2025186283A (ja) ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原
Li et al. Recombinant antigens for immunodiagnosis of cystic echinococcosis
HUP0200777A2 (en) Method of diagnosing transmissible spongiform encephalopathies
CA2893762A1 (en) Ehrlichial invasin for immunization, diagnosis, and cell delivery
Bertuccini et al. Unveiling Cryptosporidium parvum sporozoite-derived extracellular vesicles: profiling, origin, and protein composition
US20230313325A1 (en) Methods for detection of pathogenic infections using red blood cell-containing patient samples
JP7582716B2 (ja) トキソプラズマタンパク質およびインフルエンザウイルスタンパク質を含むウイルス様粒子およびこれを用いた診断方法
JP2017111095A (ja) 歯周病原菌に対するＩｇＧ抗体の検出方法
Jabbar et al. Oncospheral penetration glands are the source of the EG95 vaccine antigen against cystic hydatid disease
CZ2002160A3 (cs) Způsob imunologické detekce bakterií v darované krvi a tkáních a souprava pro tuto detekci
EP3686601B1 (en) Serological detection of plasmodium antibodies
JP2024517646A (ja) Ｂａｂｅｓｉａ組換えタンパク質を使用するＢａｂｅｓｉａの診断
KR102002104B1 (ko) 열대열 말라리아원충의 젖산탈수소효소에 특이적으로 결합하는 펩티드 및 이의 용도
CN103491979A (zh) 基于来自恶性疟原虫的红细胞前期抗原的疟疾疫苗
CN114867737A (zh) 用于潜伏型弓形虫病的新血清学标志物
JP5925983B2 (ja) ブドウ球菌感染を診断する方法
KR102021176B1 (ko) 검사용 단일클론항체 및 이를 이용한 검사 키트
CN108883174B (zh) 用于鉴定可移植的组织样品的IgG亚型测定
US20100040615A1 (en) Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof
JP5656209B2 (ja) ウシタイレリア症の病態評価を可能とする方法
EP3667322A1 (en) Serological detection of plasmodium antibodies
Singh DEVELOPMENT OF RECOMBINANT ANTIGEN BASED ELISA FOR SERODIAGNOSIS OF TOXOPLASMOSIS IN HUMANS AND ANIMALS
US20120128680A1 (en) Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
Zamin Arterial remodelling and inflammation in peripheral arterial disease
El-Aswad Use of Schistosoma mansoni calreticulin, a highly immunogenic parasite antigen, in diagnosis of and vaccination against schistosomiasis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220420

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240606

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240905

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250527

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250929